CN101721469A - medicine for treating psoriasis - Google Patents

medicine for treating psoriasis Download PDF

Info

Publication number
CN101721469A
CN101721469A CN200810194995A CN200810194995A CN101721469A CN 101721469 A CN101721469 A CN 101721469A CN 200810194995 A CN200810194995 A CN 200810194995A CN 200810194995 A CN200810194995 A CN 200810194995A CN 101721469 A CN101721469 A CN 101721469A
Authority
CN
China
Prior art keywords
medicine
antipsoriatics
raw materials
rhizoma atractylodis
salviae miltiorrhizae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810194995A
Other languages
Chinese (zh)
Inventor
张婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810194995A priority Critical patent/CN101721469A/en
Publication of CN101721469A publication Critical patent/CN101721469A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating psoriasis, which is prepared by taking radix salviae miltiorrhizae, rhizoma atractylodis, radix sileris, Wu Chia Pee and cassia nomame as raw materials. The medicine has good use effect and definite curative effect, and the effective rate is more than 70%.

Description

Antipsoriatics
Technical field:
The present invention relates to a kind of antipsoriatics.
Background technology:
Existing antipsoriatics generally adopts Western medicine etc., and to part patient unsatisfactory curative effect, what have has certain side reaction.
Summary of the invention:
The object of the present invention is to provide the good antipsoriatics of a kind of therapeutic effect.
Technical solution of the present invention is:
A kind of antipsoriatics is characterized in that: made by following raw materials by weight percent:
Radix Salviae Miltiorrhizae 30~40%
Rhizoma Atractylodis 15~25%
Radix Saposhnikoviae 10~25%
Cortex Acanthopancis 5~20%
Fructus Gleditsia 10~25%.
Described antipsoriatics, make by following raw materials by weight percent:
Radix Salviae Miltiorrhizae 35%
Rhizoma Atractylodis 20%
Radix Saposhnikoviae 15%
Cortex Acanthopancis 20%
Fructus Gleditsia 10%.
Result of use of the present invention is good, determined curative effect, and effective percentage is more than 70%.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
A kind of antipsoriatics, make by following raw materials by weight percent:
Radix Salviae Miltiorrhizae 35%
Rhizoma Atractylodis 20%
Radix Saposhnikoviae 15%
Cortex Acanthopancis 20%
Fructus Gleditsia 10%.
During making, according to the preparation method preparation of conventional granulates preparation or tablet.
Embodiment 2:
A kind of antipsoriatics, make by following raw materials by weight percent:
Radix Salviae Miltiorrhizae 40%
Rhizoma Atractylodis 15%
Radix Saposhnikoviae 10%
Cortex Acanthopancis 10%
Fructus Gleditsia 25%.
During making, according to the preparation method preparation of conventional granulates preparation or tablet.

Claims (2)

1. antipsoriatics is characterized in that: made by following raw materials by weight percent:
Radix Salviae Miltiorrhizae 30~40%
Rhizoma Atractylodis 15~25%
Radix Saposhnikoviae 10~25%
Cortex Acanthopancis 5~20%
Fructus Gleditsia 10~25%.
2. antipsoriatics according to claim 1 is characterized in that: made by following raw materials by weight percent:
Radix Salviae Miltiorrhizae 35%
Rhizoma Atractylodis 20%
Radix Saposhnikoviae 15%
Cortex Acanthopancis 20%
Fructus Gleditsia 10%.
CN200810194995A 2008-10-27 2008-10-27 medicine for treating psoriasis Pending CN101721469A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810194995A CN101721469A (en) 2008-10-27 2008-10-27 medicine for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810194995A CN101721469A (en) 2008-10-27 2008-10-27 medicine for treating psoriasis

Publications (1)

Publication Number Publication Date
CN101721469A true CN101721469A (en) 2010-06-09

Family

ID=42443420

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810194995A Pending CN101721469A (en) 2008-10-27 2008-10-27 medicine for treating psoriasis

Country Status (1)

Country Link
CN (1) CN101721469A (en)

Similar Documents

Publication Publication Date Title
CN101721616A (en) Medicine for stopping bleeding
CN101721600A (en) Medicine for treating neurasthenia
CN101721632A (en) Eupeptic medicine
CN101406631B (en) Medicament for treating hyperkinetic symptom of children
CN101721581A (en) Medicine for treating ascarid of biliary tract
CN103285099A (en) Traditional Chinese medicine mixture for treatment of constipation
CN101721603A (en) Medicine for treating acute tonsillitis
CN101721469A (en) medicine for treating psoriasis
CN102018818A (en) Medicine for treating myasthenia gravis
CN102462793A (en) Medicine for treating infantile diarrhea
CN102462735A (en) Medicine used for treating psoriasis
CN101773617A (en) Drug for treatment of asthmatic bronchitis
CN101773639A (en) Drug for treatment of Parkinson disease
CN101721541A (en) Medicine for treating erysipelas
CN101721550A (en) Medicine used after fracture taxis
CN101721649A (en) Medicine for relieving diarrhea
CN101721650A (en) Medicine for treating infantile diarrhea
CN101721473A (en) Medicine for preventing asthma
CN101721482A (en) medicine for treating pharyngitis
CN101766798A (en) Medicament for treating chronic superficial gastritis
CN101721536A (en) Medicine for treating papular urticaria
CN101721490A (en) Medicine for treating bacillary dysentery
CN101773586A (en) Drug for treatment of coronary heart disease
CN101766772A (en) Medicament for treating acute gastritis
CN101721575A (en) Medicine for treating angina pectoris

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100609